Different patterns of longitudinal changes in antinuclear antibodies titers in children with systemic lupus erythematosus and Sjögren's syndrome
Open Access
- 4 November 2024
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 33 (14) , 1594-1604
Abstract
Objective: to investigate the trend of autoantibody titers during a 2-year follow-up in pediatric systemic lupus erythematosus (pSLE) and pediatric Sjögren's syndrome (pSS). Methods: Autoantibodies testing was performed every 3-4 months during 2 years from disease onset in a cohort of children with pSLE and pSS. Results: We enrolled 21 children with pSLE and 22 children with pSS. All pSLE patients at 2 years showed ANA titers significantly lower compared to disease onset. Eleven patients (73%) were still ANA positive at 2 years, while 4 (26%) became ANA negative. At diagnosis, 12 (80%) patients showed a homogeneous pattern, while 3 (20%) patients showed a speckled pattern. The latter remained ANA positive with the same pattern; only 2 patients with a homogenous pattern converted to speckled, 4 patients with a homogeneous pattern became ANA negative. ANA negative pSLE patients showed lower levels of interferon score compared to ANA positive patients. Anti-dsDNA titers declined equally in the two groups. All patients with pSS, at disease onset, were ANA and anti-Ro positive and 14 (66%) were anti-La positive. After 2 years of follow-up, 100% remained ANA positive but showed significant lower titers. During follow-up anti-Ro and anti-La titers remained stable. Conclusion: different patterns in changes of ANA and ENA titers in pSLE and pSS were shown. At 2 years of follow-up, all pSLE patients had a lower ANA titer and 26% became negative; however, all pSS patients remained both ANA and ENA positive. This evidence may be due to different pathogenetic pathways in SLE and pSS.Keywords
Funding Information
- Ministero della Salute (Current Research funds)
This publication has 29 references indexed in Scilit:
- Persistently active interferon‐γ pathway and expansion of T‐bet+ B cells in a subset of patients with childhood‐onset systemic lupus erythematosusEuropean Journal of Immunology, 2023
- Loss of an IgG plasma cell checkpoint in patients with lupusJournal of Allergy and Clinical Immunology, 2019
- Checkpoints for Autoreactive B Cells in the Peripheral Blood of Lupus Patients Assessed by Flow CytometryArthritis & Rheumatology, 2016
- Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosusNature Immunology, 2015
- Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control studyThe Lancet Neurology, 2013
- A phase II, randomized, double‐blind, placebo‐controlled, dose‐ranging study of belimumab in patients with active systemic lupus erythematosusArthritis Care & Research, 2009
- Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosusArthritis & Rheumatism, 2003
- Ro/SS-A and La/SS-B Antibody Level Variation in Patients with Sjögren's Syndrome and Systemic Lupus ErythematosusJournal of Autoimmunity, 1998
- Expression of autoantibodies to recombinant (U1) RNP-associated 70K antigen in systemic lupus erythematosusClinical Immunology and Immunopathology, 1990
- Antibodies to sm in patients with systemic lupus erythematosus. correlation of sm antibody titers with disease activity and other laboratory parametersArthritis & Rheumatism, 1981